Product Description
The combination preparation ipratropium bromide/salbutamol is a formulation containingipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma (not an FDA approved usage)[2]. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent. Besides, it is marketed by Dey, L.P. (Napa, California) under the brand name DuoNeb as a nebulizer. In Italy it is known as Breva.
FAQs of Ipratropium Bromide:
Q: What is the application of Ipratropium Bromide?
A: Ipratropium Bromide is used in medical inhalation therapy.
Q: Who can use Ipratropium Bromide?
A: Ipratropium Bromide is suitable for adults and children above 12 years of age.
Q: What are the treatments and functions of Ipratropium Bromide?
A: Ipratropium Bromide is a bronchodilator used for treating respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma.
Q: What is the recommended dosage of Ipratropium Bromide?
A: The typical dosage of Ipratropium Bromide is 250 mcg to 500 mcg via nebulizer 3-4 times a day as prescribed by a physician.
Q: What is the storage guidance for Ipratropium Bromide?
A: Ipratropium Bromide should be stored at a temperature between 15C and 25C away from direct light and moisture.
Q: What is the purity level of Ipratropium Bromide?
A: Ipratropium Bromide has a pharmaceutical grade purity of 99%.
Q: What is the formulation form of Ipratropium Bromide?
A: Ipratropium Bromide is available in the formulation form of inhalation solution in vials containing 2.5 mL.